Method of treatment of parkinson's disease
US5756550A · kind A · utility
3Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 5, 1996 |
| Grant date | May 26, 1998 |
| Priority date | — |
| Expiry date | Sep 5, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/165
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
2-Amino-N-(1,2-diphenyl-1-methylethyl) acetamide (remacemide), or a pharmaceutically acceptable salt thereof, for use in the treatment of Parkinson's disease is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.